These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography. Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906 [TBL] [Abstract][Full Text] [Related]
5. STIR turbo SE MR imaging vs. coregistered FDG-PET/CT: quantitative and qualitative assessment of N-stage in non-small-cell lung cancer patients. Ohno Y; Koyama H; Nogami M; Takenaka D; Yoshikawa T; Yoshimura M; Ohbayashi C; Sugimura K J Magn Reson Imaging; 2007 Oct; 26(4):1071-80. PubMed ID: 17896365 [TBL] [Abstract][Full Text] [Related]
6. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer. Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572 [TBL] [Abstract][Full Text] [Related]
7. Virtual 18F-FDG PET/CT bronchoscopy for lymph node staging in non-small-cell lung cancer patients: present and future applications. Buchbender C; Herbrik M; Treffert J; Forsting M; Bockisch A; Antoch G; Heusner TA Expert Rev Med Devices; 2012 May; 9(3):241-7. PubMed ID: 22702254 [TBL] [Abstract][Full Text] [Related]
8. Computer-aided detection (CAD) and assessment of malignant lesions in the liver and lung using a novel PET/CT software tool: initial results. Hahn S; Heusner T; Zhou X; Zhan Y; Peng Z; Hamami M; Forsting M; Bockisch A; Antoch G Rofo; 2010 Mar; 182(3):243-7. PubMed ID: 19859858 [TBL] [Abstract][Full Text] [Related]
9. Accuracy of 18F-FDG PET/CT for lymph node staging in non-small-cell lung cancers. Liu BJ; Dong JC; Xu CQ; Zuo CT; Le JJ; Guan YH; Zhao J; Wu JF; Duan XH; Cao YX Chin Med J (Engl); 2009 Aug; 122(15):1749-54. PubMed ID: 19781319 [TBL] [Abstract][Full Text] [Related]
10. FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer. Ohtsuka T; Nomori H; Ebihara A; Watanabe K; Kaji M; Naruke T; Suemasu K; Uno K Ann Thorac Cardiovasc Surg; 2006 Apr; 12(2):89-94. PubMed ID: 16702929 [TBL] [Abstract][Full Text] [Related]
11. Assessment of the extent of metastases of gastrointestinal carcinoid tumors using whole-body PET, CT, MRI, PET/CT and PET/MRI. Seemann MD; Meisetschlaeger G; Gaa J; Rummeny EJ Eur J Med Res; 2006 Feb; 11(2):58-65. PubMed ID: 16504962 [TBL] [Abstract][Full Text] [Related]
12. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma. Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656 [TBL] [Abstract][Full Text] [Related]
13. Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer. Yang W; Fu Z; Yu J; Yuan S; Zhang B; Li D; Xing L; Zhao D; Mu D; Sun X; Fang Y; Huang Y; Li W Lung Cancer; 2008 Jul; 61(1):35-43. PubMed ID: 18177978 [TBL] [Abstract][Full Text] [Related]
14. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. Cerfolio RJ; Ojha B; Bryant AS; Raghuveer V; Mountz JM; Bartolucci AA Ann Thorac Surg; 2004 Sep; 78(3):1017-23; discussion 1017-23. PubMed ID: 15337041 [TBL] [Abstract][Full Text] [Related]
15. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736 [TBL] [Abstract][Full Text] [Related]
16. Integrated fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT compared to standard contrast-enhanced CT for characterization and staging of pulmonary tumors eligible for surgical resection. Quaia E; Tona G; Gelain F; Lubin E; Pizzolato R; Boscolo E; Bussoli L Acta Radiol; 2008 Nov; 49(9):995-1004. PubMed ID: 18651256 [TBL] [Abstract][Full Text] [Related]
17. Hybrid 3D visualization of the chest and virtual endoscopy of the tracheobronchial system: possibilities and limitations of clinical application. Seemann MD; Claussen CD Lung Cancer; 2001 Jun; 32(3):237-46. PubMed ID: 11390005 [TBL] [Abstract][Full Text] [Related]
18. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives. Nestle U; Kremp S; Grosu AL Radiother Oncol; 2006 Nov; 81(2):209-25. PubMed ID: 17064802 [TBL] [Abstract][Full Text] [Related]
19. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site. Pelosi E; Pennone M; Deandreis D; Douroukas A; Mancini M; Bisi G Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):15-22. PubMed ID: 16557200 [TBL] [Abstract][Full Text] [Related]
20. "Flying through" and "flying around" a PET/CT scan: Pilot study and development of 3D integrated 18F-FDG PET/CT for virtual bronchoscopy and colonoscopy. Quon A; Napel S; Beaulieu CF; Gambhir SS J Nucl Med; 2006 Jul; 47(7):1081-7. PubMed ID: 16818940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]